Argyrios Stampas

Dr. Argyrios Stampas

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2018 in Neuromodulation: Technology at the Neural Interface
Verified
Journal Article
Closed access
PDF file
ASArgyrios Stampas
Argyrios Stampas
RKRadha Korupolu
Radha Korupolu
LZLiang Zhu
Liang Zhu
CSChristopher P. Smith
Christopher P. Smith
KGKenneth Gustafson
Kenneth Gustafson

18 July 2017 in Frontiers in Physiology
Verified
Journal Article
Open access
JKJay Karri
Jay Karri
LZLarry Zhang
Larry Zhang
SLShengai Li
Shengai Li
YCYen-Ting Chen
Yen-Ting Chen
ASArgyrios Stampas
Argyrios Stampas
Sheng LiSheng Li
Sheng Li
Background: Heart rate variability (HRV), the physiological variance in the heart’s R-R interval length, can be analyzed to produce various parameters reflective of one’s autonomic balance. HRV analysis may be used to capture those autonomic aberrations associated with chronic neuropathic pain (NP) in spinal cord injury (SCI). This study assesses the capacity of HRV parameters to diagnose NP in an SCI cohort. Methods: An electrocardiogram (ECG) was collected at rest from healthy controls (HC, n=15), patients with SCI only (SCI-NP, n=11), and those with SCI and NP (SCI+NP, n=20). HRV parameters were analyzed using conventional time and frequency analysis. Results: At rest, there were no heart rate differences amongst groups. However, SCI+NP subjects demonstrated lower overall HRV, as determined by the SDNN time domain parameter, compared to either HC (p 0.15) or between C8, above vs. T1, below SCI groups (p > 0.30). Conclusions: Patients with SCI and NP exhibit a lower overall HRV, which can be determined by HRV time domain parameter SDNN. HRV analysis is an innovative modality with the capacity for objective quantification of chronic NP in patients with SCI.

19 February 2019 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
ASArgyrios Stampas
Argyrios Stampas
KGKenneth Gustafson
Kenneth Gustafson
RKRadha Korupolu
Radha Korupolu
CSChristopher Smith
Christopher Smith
LZLiang Zhu
Liang Zhu
SLSheng Li
Sheng Li
Aim: Percutaneous tibial nerve stimulation is used to decrease incontinence in chronic neurogenic bladder. We report the findings from a subset of patients in a randomized control trial of transcutaneous tibial nerve stimulation (TTNS) for bladder neuromodulation in acute spinal cord injury (SCI) in whom heart rate variability (HRV) was recorded before and after cystometrogram (CMG). The aim was to correlate autonomic nervous system (ANS) changes associated with the CMG changes after the trial using HRV analyses. Methods: The study was a double-blinded sham-controlled 2-week trial with consecutive acute SCI patients admitted for inpatient rehabilitation, randomized to TTNS vs. control sham stimulation. Pre- and Post- trial CMG were performed with concurrent 5-min HRV recordings with empty bladder and during filling. Primary outcomes were changes with CMG between/within groups and associations to the HRV findings. Results: There were 10 subjects in the TTNS group and 6 in the control group. Pre-trial baseline subject characteristics, blood pressures (BPs), and CMG were similar between groups. In both groups, the pre-trial systolic BP increased during filling CMG. After the trial, the control group had significantly increased detrusor pressure and counts of detrusor-sphincter dyssynergia on CMG, not seen in the TTNS group. Also, the control group did not maintain rising BP post-trial, which was observed pre-trial and remained in the TTNS group post-trial. HRV was able to detect a difference in the ANS response to bladder filling between groups. Post-trial HRV was significant for markers of overall increased parasympathetic nervous system activity during filling in the controls, not seen in the TTNS group. Conclusion: Preliminary evidence suggests that TTNS in acute SCI is able to achieve bladder neuromodulation via modulation of ANS functions. Clinical Trial Registration: clinicaltrials.gov, NCT02573402.

3 April 2018 in The Journal of Spinal Cord Medicine
Verified
Journal Article
Closed access
ASArgyrios Stampas
Argyrios Stampas
EDElizabeth Dominick
Elizabeth Dominick
LZLiang Zhu
Liang Zhu
Objective The objective of this study was to evaluate the impact of urinary tract infections (UTIs) acquired during acute inpatient traumatic Spinal Cord Injury (tSCI) rehabilitation on Functional Independence Measure (FIM) gains. Design Retrospective chart review of consecutive patients with tSCI admitted to an acute rehabilitation facility from 2007–2012. The primary outcome was FIM scores and the association with UTI. Results The sample included 110 patients and 70 acquired UTIs. No demographic differences were observed between groups with and without UTI. Those with UTIs had significantly lower FIM motor scores, on admission, discharge, and gain, as well as lower FIM efficiency and longer lengths of stay compared to those without a UTI. Recurrence of UTI was associated with increased length of stay, but did not impact FIM motor gains. Conclusions There was a statistically significant correlation between acquired UTIs and lower FIM motor scores on admission, gain, and discharge in tSCI rehabilitation. The correlation of UTI and decreased FIM gains are similar to other neurorehabilitation populations with UTI occurrence. UTIs are an important negative variable when measuring functional outcomes in rehabilitation. Further prospective studies should be performed to investigate this correlation.

27 May 2020 in Spinal Cord
Verified
Journal Article
Closed access
PDF file
ASArgyrios Stampas
Argyrios Stampas
CPClaudia Pedroza
Claudia Pedroza
JBJennifer N. Bush
Jennifer N. Bush
AFAdam R Ferguson
Adam R Ferguson
JKJohn L. Kipling Kramer
John L. Kipling Kramer
MHMichelle Hook
Michelle Hook

1 January 2022 in Therapeutic Advances in Neurological Disorders
Verified
Journal Article
Open access
ASArgyrios Stampas
Argyrios Stampas
MHMichelle Hook
Michelle Hook
RKRadha Korupolu
Radha Korupolu
LJLavina Jethani
Lavina Jethani
MKMahmut T. Kaner
Mahmut T. Kaner
GFGerard E. Francisco
Gerard E. Francisco
Introduction: Spasticity is a common consequence of spinal cord injury (SCI), estimated to affect up to 93% of people living with SCI in the community. Problematic spasticity affects around 35% people with SCI spasticity. The early period after injury is believed to be the most opportune time for neural plasticity after SCI. We hypothesize that clinical interventions in the early period could reduce the incidence of spasticity. To address this, we evaluated the spasticity outcomes of clinical trials with interventions early after SCI. Methods: We performed a systematic review of the literature between January 2000 and May 2021 to identify control trials, in humans and animals, that were performed early after SCI that included measures of spasticity in accordance with PRISMA guidelines. Results: Our search yielded 1,463 records of which we reviewed 852 abstracts and included 8 human trial peer-reviewed publications and 9 animal studies. The 9 animal trials largely supported the hypothesis that early intervention can reduce spasticity, including evidence from electrophysiological, behavioral, and histologic measures. Of the 8 human trials, only one study measured spasticity as a primary outcome with a sample size sufficient to test the hypothesis. In this study, neuromodulation of the spinal cord using electric stimulation of the common peroneal nerve reduced spasticity in the lower extremities compared to controls. Conclusion: Given the prevalence of problematic spasticity, there is surprisingly little research being performed in the early period of SCI that includes spasticity measures, and even fewer studies that directly address spasticity. More research on the potential for early interventions to mitigate spasticity is needed.